ABBLO PHARMA ApS: Financial statements 2024
CVR: 34080534
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 854,994 and a net result of DKK 135,215 compared with DKK 107,380 the year before. That is an increase of 6.1% compared with the year before. Equity in the 2024 report amounted to DKK -85,829. The company had 1 employee in the financial year.
- Gross Profit
- DKK 854,994
- Profit/Loss
- DKK 135,215
- Equity
- DKK -85,829
- Total Assets
- DKK 1,366,158
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 855 t. | 135 t. | -86 t. | 1 |
| 2023 | - | 806 t. | 107 t. | -221 t. | 1 |
| 2022 | - | 1.1 mio. | 301 t. | -328 t. | 1 |
| 2021 | - | 740 t. | 285 t. | -629 t. | 1 |
| 2020 | - | 376 t. | 214 t. | -914 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ABBLO PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 806,142, and the net result was DKK 107,380.
About ABBLO PHARMA ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The board consists of Mie Hjerrild Petersen (chair) and Nic Borch-Christensen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.